Page last updated: 2024-12-06

2-(2-isopropyl-5-indanyl)propionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-(2-isopropyl-5-indanyl)propionic acid, also known as **indomethacin**, is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to treat pain, fever, and inflammation. It's important for research because of its:

**1. Therapeutic Properties:**

* **Analgesic (pain relieving):** Indomethacin effectively reduces pain, especially in conditions like rheumatoid arthritis, osteoarthritis, and gout.
* **Anti-inflammatory:** It inhibits the production of prostaglandins, chemicals that contribute to inflammation, reducing swelling and redness.
* **Antipyretic (fever reducing):** Indomethacin can lower body temperature in cases of fever.

**2. Research Applications:**

* **Drug Development:** Understanding the mechanisms of action of indomethacin has helped researchers develop other NSAIDs with improved efficacy and safety profiles.
* **Inflammation Research:** It serves as a valuable tool in studying the inflammatory process and the role of prostaglandins.
* **Cancer Research:** Indomethacin has shown potential anti-cancer activity in some studies. Its effects on cell growth and proliferation are being investigated for potential therapeutic applications.
* **Neurological Research:** Indomethacin is being investigated for its potential role in treating neurological conditions like Alzheimer's disease and Parkinson's disease.

**3. Understanding its Mechanism of Action:**

* **Cyclooxygenase (COX) inhibition:** Indomethacin primarily works by inhibiting the COX enzymes, COX-1 and COX-2. These enzymes are responsible for producing prostaglandins, which contribute to inflammation, pain, and fever.
* **Other Targets:** Indomethacin also interacts with other targets, including the nuclear factor kappa B (NF-κB) pathway, which plays a crucial role in inflammation and immune responses.

**4. Side Effects and Safety:**

* **Gastrointestinal (GI) problems:** Indomethacin can cause stomach ulcers, heartburn, and other GI issues.
* **Cardiovascular risks:** It may increase the risk of heart attack and stroke in some individuals.
* **Hepatotoxicity:** In rare cases, indomethacin can damage the liver.

**Overall:**

Indomethacin is a valuable tool in research and clinical medicine due to its therapeutic properties, its contribution to understanding inflammation, and its potential applications in diverse areas of research, including drug development, cancer, and neurological disorders. However, its use is accompanied by potential side effects that need to be carefully monitored.

2-(2-isopropyl-5-indanyl)propionic acid: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68769
CHEMBL ID2105045
SCHEMBL ID287354
MeSH IDM0082860

Synonyms (30)

Synonym
isoprofeno [inn-spanish]
isoprofene [inn-french]
up 517-03
5-indanacetic acid, 2-isopropyl-alpha-methyl-
isoprofeno [spanish]
2-(2-isopropyl-5-indanyl)propionic acid
isoprofen [inn]
2,3-dihydro-alpha-methyl-2-(1-methylethyl)-1h-indene-5-acetic acid
1h-indene-5-acetic acid, 2,3-dihydro-alpha-methyl-2-(1-methylethyl)-
isoprofenum [inn-latin]
2-isopropyl-alpha-methyl-5-indanacetic acid
up-517-03
isoprofen
2-(2-propan-2-yl-2,3-dihydro-1h-inden-5-yl)propanoic acid
57144-56-6
unii-18751gad0p
isoprofenum
isoprofeno
18751gad0p ,
isoprofene
CHEMBL2105045
SCHEMBL287354
2-isopropyl-.alpha.-methyl-5-indanacetic acid
RYDUZJFCKYTEHX-UHFFFAOYSA-N
2-(2-isopropylindan-5-yl)propionic acid
2-(2-isopropyl-2,3-dihydro-1h-inden-5-yl)propanoic acid
2-(2-isopropylindan-5-yl)-propionic acid
DTXSID30866616
2-[2-(propan-2-yl)-2,3-dihydro-1h-inden-5-yl]propanoic acid
Q27251983
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1146532Analgesic activity in po dosed rat assessed as inhibition of phenylbenzoquinone-induced writhing administered in 1% w/v arabic gum1978Journal of medicinal chemistry, Sep, Volume: 21, Issue:9
Antiinflammatory and analgesic diastereoisomeric derivatives of indan-5-acetic acid.
AID1146533Antiinflammatory activity in po dosed rat assessed as inhibition of carrageenan-induced edema administered in 1% w/v arabic gum1978Journal of medicinal chemistry, Sep, Volume: 21, Issue:9
Antiinflammatory and analgesic diastereoisomeric derivatives of indan-5-acetic acid.
AID1146531Gastrointestinal toxicity in po dosed rat assessed as ulcerogenic activity after 6 hrs administered in 1% w/v arabic gum1978Journal of medicinal chemistry, Sep, Volume: 21, Issue:9
Antiinflammatory and analgesic diastereoisomeric derivatives of indan-5-acetic acid.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]